← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
C3.ai grew revenue and reduced free-cash-flow burn, but losses and stock compensation remained large.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +25.3% to $389.1MOK
- Profitability — Net loss widened to $288.7MWatch
- Cash quality — FCF improved to -$44.4MNote
- Margins — Gross margin +313 bps; FCF margin +1679 bpsNote
- Dilution watch — SBC +7.1% to $231.0MWatch
- Insiders — 2 buys / 29 sellsNote
- Accounting — M-score clean; EQ greyWatch
Business
C3.ai sells enterprise AI software, including the C3 Agentic AI Platform, C3 AI Applications, and C3 Generative AI.
Where the revenue comes from
Fiscal 2026, as C3.ai, Inc. reports it. History and quarterly detail are in the app.
- Cost of subscription$227.1M
- Software Licenses$43.8M
- Professional services$23.2M
Leadership changes
From C3.ai, Inc.'s own filings, the day they're filed.
- John C. Dwyer · director · departureeff. 2026-08-25
- Stephen Ehikian · Chief Executive Officer · appointmenteff. 2025-09-01
- Kenneth A. Goldman · director · appointmenteff. 2025-05-21
Latest filings
- 8-K · Company announcement2026-09-02
- DEF 14A · Annual proxy (pay & governance)2026-08-28
- 8-K · Company announcement2026-08-27
- 8-K · Company announcement2026-07-17
- 10-K · Annual report2026-06-24
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about C3.ai, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.